par Roosens, Bram;Cosyns, Bernard ;Lancellotti, Patrizio;Laroche, Cécile;Selton-Suty, Christine;Pasquet, Agnès;De Sutter, Johan;Unger, Philippe ;Paelinck, Bernard;Vermeersch, Paul;Motoc, Andreea;Galloo, Xavier;Iung, Bernard;Habib, Gilbert
Référence Journal of Clinical Medicine, 13, 5, 1371
Publication Publié, 2024-03
Référence Journal of Clinical Medicine, 13, 5, 1371
Publication Publié, 2024-03
Article révisé par les pairs
Résumé : | (1) Background: infective endocarditis (IE) is a significant health concern associated with important morbidity and mortality. Only limited, often monocentric, retrospective data on IE in Belgium are available. This prospective study sought to assess the clinical characteristics and outcomes of Belgian IE patients in the ESC EORP European endocarditis (EURO-ENDO) registry; (2) Methods: 132 IE patients were identified based on the ESC 2015 criteria and included in six tertiary hospitals in Belgium; (3) Results: The average Belgian IE patient was male and 62.8 ± 14.9 years old. The native valve was most affected (56.8%), but prosthetic/repaired valves (34.1%) and intracardiac device-related (5.3%) IE are increasing. The most frequently identified microorganisms were S. aureus (37.2%), enterococci (15.5%), and S. viridans (15.5%). The most frequent complications were acute renal failure (36.2%) and embolic events (23.6%). Cardiac surgery was effectively performed when indicated in 71.7% of the cases. In-hospital mortality occurred in 15.7% of patients. Predictors of mortality in the multivariate analysis were S. aureus (HR = 2.99 [1.07–8.33], p = 0.036) and unperformed cardiac surgery when indicated (HR = 19.54 [1.91–200.17], p = 0.012). (4) Conclusion: This prospective EURO-ENDO ancillary analysis provides valuable contemporary insights into the profile, treatment, and clinical outcomes of IE patients in Belgium. |